Enzo Therapeutics, Inc. v. Yeda Research & Development Co. of the Weizmann Institute of Science

OPINION AND ORDER

DOUMAR, District Judge.

Presently before the Court is a motion by Defendant Jon W. Dudas, in his capacity as Director of the United States Patent and Trademark Office (the “Director”), to dismiss claims filed against him on July 3, 2006, by Plaintiff Enzo Therapeutics, Inc. (“Enzo”). The underlying lawsuit, filed pursuant to 35 U.S.C. § 146, asserts four claims against the Director and Yeda Research and Development Company (“Teda”) that emerged from an interference proceeding (the “Interference”) conducted by the Board of Patent Appeals and Interference (the “Board”). Count I…